Cost-utility of COBRA-light versus COBRA therapy in patients with early rheumatoid arthritis: the COBRA-light trial

OBJECTIVE: To evaluate if COmbinatie therapie Bij Reumatoïde Artritis (COBRA)-light therapy is cost-effective in treating patients with early rheumatoid arthritis (RA) compared with COBRA therapy. METHODS: This economic evaluation was performed next to the open-label, randomised non-inferiority COBR...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:RMD Open
Main Authors: ter Wee, Marieke M, Coupé, Veerle MH, den Uyl, Debby, Blomjous, Birgit S, Kooijmans, Esmee, Kerstens, Pit JSM, Nurmohamed, Mike T, van Schaardenburg, Dirkjan, Voskuyl, Alexandre E, Boers, Maarten, Lems, Willem F
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2017
Assuntos:
Rheumatoid Arthritis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5663254/
https://ncbi.nlm.nih.gov/pubmed/29119006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2017-000502
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados